These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27658836)

  • 1. Attitudes of Croatian psychiatrists towards long-acting injectable antipsychotics.
    Ciglar M; Bjedov S; Maleković H
    Psychiatr Danub; 2016 Sep; 28(3):273-277. PubMed ID: 27658836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of Croatian patients with severe mental illness towards long-acting injectable antipsychotics.
    Bjedov S; Ciglar M; Maleković H
    Psychiatr Danub; 2016 Sep; 28(3):278-283. PubMed ID: 27658837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.
    Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):23S-9S. PubMed ID: 23945064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.
    Gundugurti PR; Nagpal R; Sheth A; Narang P; Gawande S; Singh V
    Asian J Psychiatr; 2017 Dec; 30():88-93. PubMed ID: 28843143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey.
    Oguchi Y; Miyake N; Ando K
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):417-423. PubMed ID: 38634351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Concurrent Oral and Long-Acting Injectable Antipsychotic Prescribing at the Minneapolis Veterans Affairs Health Care System.
    Dimitropoulos E; Drogemuller L; Wong K
    J Clin Psychopharmacol; 2017 Oct; 37(5):605-608. PubMed ID: 28816923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.
    Samalin L; Garnier M; Auclair C; Llorca PM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicians' attitudes toward the use of long-acting injectable antipsychotics.
    Samalin L; Charpeaud T; Blanc O; Heres S; Llorca PM
    J Nerv Ment Dis; 2013 Jul; 201(7):553-9. PubMed ID: 23817151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of attitudes toward long-acting injectable antipsychotics among psychiatrists and patients.
    Kim SW; Lee YH; Jang JE; Yoo T; Kim JM; Shin IS; Yoon JS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):80-6. PubMed ID: 23325306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of psychiatrists toward antipsychotic depot medication.
    Heres S; Hamann J; Kissling W; Leucht S
    J Clin Psychiatry; 2006 Dec; 67(12):1948-53. PubMed ID: 17194274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    James BO; Omoaregba JO; Raji SO; Imishue OE; Okonoda KM; Nyamali YI; Famuyiwa PA; Correll CU
    Psychiatry Res; 2017 Feb; 248():134-139. PubMed ID: 28063386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
    Sugawara N; Yasui-Furukori N; Yamazaki M; Shimoda K; Mori T; Sugai T; Suzuki Y; Someya T
    PLoS One; 2014; 9(1):e86826. PubMed ID: 24466260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of European physicians towards the use of long-acting injectable antipsychotics.
    Patel MX; Bent-Ennakhil N; Sapin C; di Nicola S; Loze JY; Nylander AG; Heres S
    BMC Psychiatry; 2020 Mar; 20(1):123. PubMed ID: 32169077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain.
    Arango C; Baeza I; Bernardo M; Cañas F; de Dios C; Díaz-Marsá M; García-Portilla MP; Gutiérrez-Rojas L; Olivares JM; Rico-Villademoros F; Rodríguez-Jiménez R; Sánchez-Morla EM; Segarra R; Crespo-Facorro B
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(2):92-105. PubMed ID: 29954707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.
    Llorca PM; Abbar M; Courtet P; Guillaume S; Lancrenon S; Samalin L
    BMC Psychiatry; 2013 Dec; 13():340. PubMed ID: 24359031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the Use of Long-Acting Injectable Antipsychotics in the Province of Manitoba, Canada.
    Janzen D; Bolton J; Kuo IF; Leong C; Alessi-Severini S
    J Clin Psychopharmacol; 2020; 40(1):6-13. PubMed ID: 31834085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of Psychiatrists Toward the Use of Long-Acting Injectable Antipsychotics: An Online Survey Study From India.
    Grover S; Sahoo S; Mehra A
    J Clin Psychopharmacol; 2019; 39(6):611-619. PubMed ID: 31688382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.